focus -WSS

focus

author：fashion 2025-10-01 18:33:11 - browse：74794

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

WSS

How Vertex's cystic fibrosis drug is changing patients' lives

Hearing on Medicare drug price negotiation gets unusually heated

Second xenotransplant done with gene

Inside the fall of star MIT scientist David Sabatini

Did the public have the right to know Arthur Ashe had AIDS?

Senators: Long

focus

focus

focus

Hollywood unions extend contract negotiations for actors

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Community addresses injustice for Long Island mothers

Medicare proposal to cover medical devices draws a mixed reaction

Senators: Long

Psychedelics group wrestles with new pharma identity

It's been 20 years since Dolly the sheep. Where's my clone?

Virginia high school admissions case could be legal follow

PhRMA sues HHS over Medicare drug price negotiation

focus

Grail is spending more than ever lobbying Congress

Lasker Awards 2023: Winners in biomedical research

Connecting traumatic brain injury and domestic violence

How Vertex's cystic fibrosis drug is changing patients' lives

Inside the fall of star MIT scientist David Sabatini

Make 'food is medicine' a key part of White House nutrition meeting

hotspot

Wikipedia

hotspot

explore